Creative Biolabs rAb Blog

Menu

Skip to content
  • Therapeutic Antibody R&D
  • Recombinant Antibody R&D
  • Antibody Engineering R&D
  • News

Recombinant Antibody Products

Creative Biolabs is a pioneer of recombinant antibody (rAb) discovery and manufacture, providing the most comprehensive list of rAb products in the world. We have developed proprietary procedures for Hi-Affi™ recombinant antibody production, with optimized library construction and screening processes using hybridoma or phage display technology.

Learn More

Functional Antibody Products

At Creative Biolabs, our functional antibody products are produced and purified using specialized techniques, offering numerous features suitable for research in the activation, blocking, and neutralization of immune cell functions.

Learn More

Engineered Antibody Products

Creative Biolabs provides a diverse range of engineered antibody products, dedicated to providing clients with effective, precise, and safe antibody solutions. Our products use advanced antibody screening and engineering techniques, ensuring each one has exceptional specificity for accurately identifying targets while minimizing interference from non-specific binding.

Learn More

High Throughput Antibody Production Services

Creative Biolabs has launched high-throughput antibody production services, delivering quality antibody products to clients worldwide efficiently and rapidly. Till now, our platform has been meticulously constructed to encompass a broad range of antibody formats, from single-domain antibodies to full-length IgGs.

Learn More
21Feb/20

A Brief Introduction of MERS-CoV

February 21, 2020Recombinant Antibody R&DCoronavirus, MERS-CoV, SARS-CoVbiorab

In 2012, MERS-CoV (Middle East Respiratory Syndrome Coronavirus) was found in Saudi Arabia. The early labor symptoms caused by the viruse are similar to SARS (Severe Acute Respiratory Syndrome). Therefore, MERS-CoV isRead More…

19Feb/20

Focus on SARS-CoV-2

February 19, 2020Recombinant Antibody R&DCoronavirus, COVID-19, SARS-CoV-2biorab

As we all know, a new crown pneumonia epidemic suddenly swept China at the end of 2019 and even affected the whole world. On January 30, 2020, WHO announced that the epidemicRead More…

18Feb/20

Do You Know SARS-CoV ?

February 18, 2020Recombinant Antibody R&DCoronavirus, MERS-CoV, SARS-CoVbiorab

In 2002, severe acute respiratory syndrome occurred in Guangdong, China, and spread throughout the world, causing a global epidemic of infectious diseases. The culprit of this incident was SARS-CoV (Severe Acute RespiratoryRead More…

17Feb/20

What is Coronavirus ?

February 17, 2020Recombinant Antibody R&DCoronavirus, MERS-CoV, SARS-CoVbiorab

Recently, a virus called SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) caused an epidemic with pneumonia as the main symptom. This SARS-CoV-2 is a coronavirus, so what exactly is a coronavirus? OverviewRead More…

26Jun/19

Cancer Res: The Causes of Chemotherapy Resistance in Breast Cancer

June 26, 2019NewsBreast Cancer, Chemotherapy Resistancebiorab

According to a study recently published in Cancer Research by researchers and colleagues at the Belvich Institute of Biomedicine at the University of Barcelona, a large number of replicated chromosome regions areRead More…

17Apr/19

Scientists Found that Potassium Ions are the Key to Controlling the Anticancer Ability of T cells

April 17, 2019NewsCancer, Potassium Ion, T cellbiorab

A study led by scientists at the Center for Cancer Research (CCR) at the American National Cancer Institute (NCI) has revealed a way to promote the continued growth of tumors in theRead More…

19Feb/19

3D Bio-printing Model Changes Anti-cancer Drug Development and Anti-tumor Therapy

February 19, 2019News3D Model, Bio-printing, Cancerbiorab

Researchers at the University of Minnesota have developed a way to study cancer cells, which could lead to new and more effective treatments. They have developed a new method to study theseRead More…

01Feb/19

Nine characteristics shared by the most successful mAb

February 1, 2019News, Therapeutic Antibody R&Dantibody discovery, monoclonal antibody drug, therapeutic antibodybiorab

The path to finding a therapeutic antibody that leads to significant medical improvements is often complicated, long, and costly. Many criteria have to be taken into account in order to begin theRead More…

20Dec/18

Nat Genet:Scientists Discover New Target for Immunotherapy Following 2018 Nobel Prize for Medicine

December 20, 2018News, Therapeutic Antibody R&Dantibody discovery, immunotherapy, monoclonal antibody drug, therapeutic antibodybiorab

Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of immunotherapy in oncology. According to a recent study published in the international journalRead More…

27Sep/18

Antibody Combo Knocks Down HIV in Clinical Trials

September 27, 2018News, Therapeutic Antibody R&Dantibody combination, blocking antibody, hiv immunology, monoclonal antibody, monoclonal antibody drug, therapeutic antibodybiorab

A mix of two monoclonal antibodies against HIV tamped down virus levels in patients not taking antiretroviral medication, according to the results of two early-stage clinical trials reported in nature. After several infusionsRead More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • Next »

Categories

  • Antibody Engineering R&D
  • Cancer Immunotherapy
  • News
  • Recombinant Antibody R&D
  • Therapeutic Antibody R&D

Recent Posts

  • CD73 Inhibition: A Promising Strategy for Overcoming Immune Evasion in Colorectal Cancer
  • A Breakthrough in Influenza Defense: Discovering Antibodies for Broad-Spectrum Protection
  • Discovery of Highly Neutralizing Human Antibodies Targeting Pseudomonas aeruginosa for Treatment of Drug-Resistant Infections
  • Two New Strategies Targeting Siglec-7 Show Promise in Treating Ovarian Cancer
  • Researchers Revealed the Feasibility and Clinical Prospects of Targeting SLC7A11 for the Treatment of Osteosarcoma

Archives

Contact Us

USA – UK

Copyright © Creative Biolabs rAb Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Therapeutic Antibody R&D
  • Recombinant Antibody R&D
  • Antibody Engineering R&D
  • News